3-(4-Amino-5-oxo-5H-chromeno[4,3-d]pyrimidin-2-yl)phenyl thiophene-2-sulfonate

ID: ALA5272170

Max Phase: Preclinical

Molecular Formula: C21H13N3O5S2

Molecular Weight: 451.49

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(-c2cccc(OS(=O)(=O)c3cccs3)c2)nc2c1c(=O)oc1ccccc12

Standard InChI:  InChI=1S/C21H13N3O5S2/c22-19-17-18(14-7-1-2-8-15(14)28-21(17)25)23-20(24-19)12-5-3-6-13(11-12)29-31(26,27)16-9-4-10-30-16/h1-11H,(H2,22,23,24)

Standard InChI Key:  FFWMEQBIYVETAG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -2.4312    0.2070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7166    0.6193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0047    0.2073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0047   -0.6177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7148   -1.0295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4312   -0.6213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1467   -1.0339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8645   -0.6198    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8663    0.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1518    0.6228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1570    1.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8787    1.8592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5886    1.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5834    0.6132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1467   -1.8592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7148   -1.8547    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2901    0.6200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2898    1.4452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4229    1.8559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1378    1.4432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1394    0.6221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4275    0.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8540    0.2095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5686    0.6221    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2833    0.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9820    1.3380    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1568    1.3380    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0367    0.5450    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.5886   -0.0679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1762   -0.7822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3695   -0.6107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  1  6  2  0
  6  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  2  0
  1 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  9 14  1  0
  7 15  2  0
  5 16  1  0
 17  3  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 24 27  2  0
 28 25  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 25  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5272170

    ---

Associated Targets(Human)

CNE-2 (385 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAL-27 (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TERT Tchem Telomerase reverse transcriptase (2428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.49Molecular Weight (Monoisotopic): 451.0297AlogP: 3.81#Rotatable Bonds: 4
Polar Surface Area: 125.38Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.29CX LogP: 4.85CX LogD: 4.85
Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.25Np Likeness Score: -1.23

References

1. Lv N, Sun M, Liu C, Li J..  (2017)  Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.,  27  (19): [PMID:28888820] [10.1016/j.bmcl.2017.08.044]

Source